DNA sequence selectivity of cisplatin analogues in intact human cells

Chemico-Biological Interactions

Volumn 110, Issue 1-2, 1998, Pages 27-37

  Murray, Vincent ^a   Whittaker, Joanne ^a   McFadyen, W David ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

CHIP; Cisplatin; DNA damage; HeLa cells; Sequence specificity; Tetraplatin

Indexed keywords

CARBOPLATIN; CISPLATIN DERIVATIVE; IPROPLATIN; TETRAPLATIN; TRANSPLATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CROSS LINKING; DNA DAMAGE; DNA PURIFICATION; DNA SEQUENCE; ENZYME SPECIFICITY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LIGAND BINDING; NEUROTOXICITY; PROTEIN DNA INTERACTION;

ANTINEOPLASTIC AGENTS; CISPLATIN; DNA DAMAGE; DNA, NEOPLASM; DNA-DIRECTED DNA POLYMERASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HELA CELLS; HUMANS; ORGANOPLATINUM COMPOUNDS; POLYMERASE CHAIN REACTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031953317     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00110-5     Document Type: Article

References (22)

1. Loeher P.J., Einhorn L.H. Drugs five years later, cisplatin. Ann. Intern. Med. 100:1984;704-713.
2. Bruhn S.L., Toney J.H., Lippard S.J. Biological processing of DNA modified by platinum compounds. Prog. Inorg. Chem.: Bioinorg. Chem. 38:1991;478-517.
3. Dabrowiak J.C., Bradner W.T. Platinum antitumour agents. Prog. Med. Chem. 24:1987;129-158.
4. Christian M.C. The current status of new Platinum analogues. Semin. Oncol. 19:1992;720-733.
5. Harrap K.R. Initiatives with Platinum- and Quinazoline-based antitumor molecules. Cancer Res. 55:1995;2761-2768.
6. J. Reedijk, Improved understanding in platinum antitumour chemistry, Chem. Commun. (1996) 801-806.
7. Kelland L.R., McKeage M.J. Platinum drugs currently in clinical trial. Curr. Opin. Invest. Drugs. 2:1993;571-580.
8. Sanderson B.J.S., Ferguson L.R., Denny W.A. Mutagenic and carcinogenic properties of platinum-based anticancer drugs. Mutat. Res. 355:1996;59-70.
9. Murray V., Motyka H., England P.R., Wickham G., Lee H.O., Denny W.A., McFadyen W.D. The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues. J. Biol. Chem. 267:1992;18805-18809.
10. Murray V., Motyka H., England P.R., Wickham G., Lee H.O., Denny W.A., McFadyen W.D. An investigation of the sequence specific interaction of cis-diamminedichloroplatinum(II) and four analogues (including two acridine-tethered complexes) with DNA inside human cells. Biochemistry. 31:1992;11812-11817.
11. Comess K.M., Burstyn J.N., Essigmann J.M., Lippard S.J. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts. Biochemistry. 31:1992;3975-3990.
12. Wu J.C., Manuelidis L. Sequence definition and organization of a human repeated DNA. J. Mol. Biol. 142:1980;363-386.
13. Jorgensen A.L., Bostock C.J., Bak A.L. Chromosome-specific subfamilies within human alphoid repetitive DNA. J. Mol. Biol. 187:1986;185-196.
14. Braddock P.D., Connors T.A., Jones M., Khokhar A.R., Melzack D.H., Tobe M.L. Structure and activity relationships of platinum complexes with anti-tumour activity. Chem.-Biol. Interact. 11:1975;145-161.
15. Anderson W.K., Quagliato D.A., Haugwitz R.D., Narayanan V.L., Wolpert-DeFilippes M.K. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane. Cancer Treat. Rep. 70:1986;997-1002.
16. Vollano J.F., Al-Baker S., Dabrowiak J.C., Schurig J.E. Comparative antitumor studies on platinum(II) and platinum(IV) complexes containing 1,2-diaminocyclohexane. J. Med. Chem. 30:1987;716-719.
17. +. J. Med. Chem. 32:1989;128-136.
18. 2 and water and N,N-dimethylacetamide adducts, J. Chem. Res. (M) (1983) 2801-2860.
19. Harrison R.C., McAuliffe C.A., Zaki A.M. An efficient route for the preparation of highly water soluble platinum(II) antitumour agents. Inorg. Chim. Acta. 46:1980;L15-L16.
20. Murray V., Martin R.F. The sequence specificity of bleomycin-induced DNA damage in intact cells. J. Biol. Chem. 260:1985;10389-10391.
21. Murray V. Improved double-stranded DNA sequencing using the linear polymerase chain reaction. Nucleic. Acids Res. 17:1989;8889.
22. V. Murray, J.K. Whittaker, M.D. Temple, W.D. McFadyen, Interaction of eleven cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues, Biochem. Biophys. Acta (1997) (in press).